A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

476

Participants

Timeline

Start Date

July 25, 2022

Primary Completion Date

July 25, 2023

Study Completion Date

October 31, 2023

Conditions
Diabetes Mellitus, Type 2
Interventions
BIOLOGICAL

semaglutide injection

The subject will receive either a dose semaglutide once weekly (subcutaneous (s.c.) injection). The initial dose of 0.25 mg is s.c. once weekly, and the dose is increased to 0.5 mg after 4 weeks of administration, and the dose is increased to 1 mg after 4 weeks of 0.5 mg administration, and the dose is continued at a stable dose of 1 mg for 24 weeks.Treatment duration 32 weeks.

Trial Locations (35)

61000

CANGZHOU People's Hospital, Cangzhou

61001

CANGZHOU Central Hospital, Cangzhou

61013

Cang zhou Hospital of Integrated Traditional Chinese and Western of Hebei Province, Cangzhou

200030

Huadong Hospital Affillated to Fudan University, Shanghai

Zhongshan Hospital, Shanghai

201299

Shanghai Pudong New Area People's Hospital, Shanghai

210011

The Second Affiliated Hospital of Nanjing Medical University, Nanjing

212001

Affiliated Hospital of Jiangsu University, Zhengjiang

213003

Changzhou No.2 People's Hospital, Changzhou

215006

The First Affiliated Hospital OF Soochow University, Suzhou

221000

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

Xuzhou Cancer Hospital, Xuzhou

222006

The Second People's Hospital of Lianyungang, Lianyungang

223000

Huai'an Second People's Hospital, Huaian

The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian

230601

The Second Affiliated Hospital of Anhui Medical University, Hefei

250000

Central Hospital Affiliated to Shandong First Medical University, Jinan

310009

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

414000

Yueyang People's Hospital, Yueyang

435000

Huangshi Central Hospital, Huangshi

443003

Yichang Central People's Hospital, Yichang

450014

The Second Affiliated Hospital of Zhengzhou University, Zhengzhou

450052

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang

473000

Nanyang First People's Hospital, Nanyang

Nanyang Second General Hospital, Nanyang

The First Affiliated Hospital of Nanyang Medical College, Nanyang

510000

NanFang Hospital, Guangzhou

516003

Huizhou Central People's Hospital, Guangdong

710000

The First Affiliated Hospital of Xi'an jiaotong university, Xi'an

050000

Shijiazhuang Second Hospital, Shijiazhuang

014000

BaogangHospital of InnerMongolia, Baotou

010000

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

0799-6881723

Pingxiang People's Hospital, Pingxiang

048006

Jincheng Grand Hospital, Jincheng

044099

Shanxi Yuncheng Central Hospital, Yuncheng

All Listed Sponsors
lead

Hangzhou Jiuyuan Gene Engineering Co. Ltd.,

INDUSTRY